Long-term follow-up of persisting mixed chimerism after partially T cell-depleted allogeneic stem cell transplantation
N Schaap, A Schattenberg, E Mensink, F Preijers… - Leukemia, 2002 - nature.com
Using red cell phenotyping (RCP) and/or cytogenetics (CYT) we identified 19 patients with
persisting mixed chimerism (MC) among 231 patients transplanted with partially T cell …
persisting mixed chimerism (MC) among 231 patients transplanted with partially T cell …
Very long term stability of mixed chimerism after allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies
E Levrat, E Roosnek, S Masouridi, B Mohty… - Bone marrow …, 2015 - Wiley Online Library
The objective of this study is to analyze the evolution of chimerism of all patients
transplanted for hematologic malignancies in our unit during a 20‐year period, alive without …
transplanted for hematologic malignancies in our unit during a 20‐year period, alive without …
[HTML][HTML] Chimerism patterns of long-term stable mixed chimeras posthematopoietic stem cell transplantation in patients with nonmalignant diseases: follow-up of long …
A Stikvoort, J Gertow, M Sundin, M Remberger… - Biology of Blood and …, 2013 - Elsevier
Long-term stable mixed chimerism (MC) is a rare phenomenon after hematopoietic stem cell
transplantation (HSCT) characterized by 5% to 95% residual recipient hematopoietic cells …
transplantation (HSCT) characterized by 5% to 95% residual recipient hematopoietic cells …
Monthly prospective analysis of hematopoietic chimerism after allogeneic hematopoietic cell transplantation
KH Lee, JH Lee, SJ Choi, S Kim, M Seol… - Bone marrow …, 2003 - nature.com
Hematopoietic chimerism (HpC) was assayed monthly using a sensitive, polymerase chain
reaction (PCR)-based method in consecutive patients. Between January 1998 and April …
reaction (PCR)-based method in consecutive patients. Between January 1998 and April …
[HTML][HTML] Characterization of mixed chimerism in patients with chronic myeloid leukemia transplanted with T-cell-depleted bone marrow: involvement of different …
E Roux, K Abeti, D Speiser, C Helg, B Chapuis… - Blood, 1993 - Elsevier
We have characterized mixed chimerism (MC) in five patients with chronic myeloid leukemia
(CML) who received transplants with T-cell—depleted bone marrow (BM) and who relapsed …
(CML) who received transplants with T-cell—depleted bone marrow (BM) and who relapsed …
[HTML][HTML] Partial chimerism after T-cell-depleted allogeneic bone marrow transplantation in leukemic HLA-matched patients: a cytogenetic documentation
MF Bertheas, D Maraninchi, M Lafage, J Fraisse… - Blood, 1988 - Elsevier
We evaluated serially by cytogenetics the blood and marrow chimerism of 38 leukemic
recipients of HLA-matched bone marrow transplants (BMT) who were prepared by high …
recipients of HLA-matched bone marrow transplants (BMT) who were prepared by high …
Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia
S Mackinnon, L Barnett, G Heller, RJ O'Reilly - 1994 - ashpublications.org
Determining both lymphoid chimerism and the presence of minimal residual disease after
allogeneic bone marrow transplantation (BMT) for chronic myelogenous leukemia (CML) …
allogeneic bone marrow transplantation (BMT) for chronic myelogenous leukemia (CML) …
Lineage-specific chimaerism quantification after T-cell depleted peripheral blood stem cell transplantation
Patients that receive a T-cell depleted (TCD) hematopoietic stem cell transplantation (SCT)
show higher risk of graft failure/rejection and of disease relapse than those that receive …
show higher risk of graft failure/rejection and of disease relapse than those that receive …
Increasing mixed haematopoietic chimaerism after BMT with total depletion of CD4+ and partial depletion of CD8+ lymphocytes is associated with a higher incidence …
J Serrano, J Roman, C Herrera, JA Castillejo… - Bone marrow …, 1999 - nature.com
In this study we analysed the incidence and clinical impact of the persistence of host
haemopoiesis (mixed chimaerism, MC) after allogeneic BMT in 35 consecutive patients with …
haemopoiesis (mixed chimaerism, MC) after allogeneic BMT in 35 consecutive patients with …
Mixed hematopoietic chimerism at day 90 following allogenic myeloablative stem cell transplantation is a predictor of relapse and survival
R Lamba, E Abella, D Kukuruga, J Klein, S Savasan… - Leukemia, 2004 - nature.com
We retrospectively analyzed the prognostic significance of mixed chimerism and associated
clinical parameters in 80 patients following unmanipulated allogenic stem cell …
clinical parameters in 80 patients following unmanipulated allogenic stem cell …